Neith Corporation (6236.TWO)
TWD 28.95
(0.0%)
TWD 28.95
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -150.31 Million TWD | 12.29% |
| 2022 | -171.36 Million TWD | -391.29% |
| 2021 | -34.88 Million TWD | -41.51% |
| 2020 | -24.65 Million TWD | 0.0% |
| 2019 | - TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -142.16 Million TWD | 5.42% |
| 2024 Q2 | -128.02 Million TWD | 9.95% |
| 2023 Q3 | -159.26 Million TWD | 3.89% |
| 2023 FY | -150.31 Million TWD | 12.29% |
| 2023 Q1 | -172.81 Million TWD | 0.0% |
| 2023 Q2 | -165.7 Million TWD | 4.11% |
| 2023 Q4 | -150.31 Million TWD | 5.62% |
| 2022 Q4 | - TWD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 43.1% |
| Level Biotechnology Inc. | -453.9 Million TWD | 66.885% |
| Sagittarius Life Science Corp | -120.57 Million TWD | -24.667% |
| NeoCore Technology Co., Ltd. | -196.39 Million TWD | 23.466% |
| TaiMed Biologics Inc. | 499.84 Million TWD | 130.071% |
| GlycoNex Incorporation | -148.56 Million TWD | -1.174% |
| GeneReach Biotechnology Corp. | 40.26 Million TWD | 473.295% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 208.925% |
| SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 42.757% |
| Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 591.566% |
| Visgeneer Inc. | 31.28 Million TWD | 580.472% |
| Mycenax Biotech Inc. | 207 Million TWD | 172.611% |
| Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 77.915% |
| G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | -11.962% |
| Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 124.184% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | -160.694% |
| Enimmune corporation | -314.15 Million TWD | 52.154% |
| TaiRx, Inc. | -147.86 Million TWD | -1.651% |
| EirGenix Inc. | -4.58 Billion TWD | 96.724% |
| BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | -77.331% |
| Sunny Pharmtech Inc. | 120.87 Million TWD | 224.357% |
| Lin BioScience, Inc. | -3.21 Billion TWD | 95.329% |
| BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 52.646% |
| Feng Chi Biotech Corp. | -19.81 Million TWD | -658.648% |
| Bio Preventive Medicine Corp. | 31.8 Million TWD | 572.542% |
| Lukas Biomedical Inc. | 50.75 Million TWD | 396.15% |
| RBC Bioscience Corporation | 422.18 Million TWD | 135.603% |
| BiOptic Inc. | 12.59 Million TWD | 1293.702% |
| BRIM Biotechnology, Inc. | -944.4 Million TWD | 84.084% |
| Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | -48.11% |
| Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | 8.999% |
| VBI | -25.31 Million TWD | -493.739% |
| CHO Pharma, Inc. | -203.79 Million TWD | 26.243% |
| Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | -95.098% |
| Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 147.737% |
| Advagene Biopharma Co., Ltd. | -64.32 Million TWD | -133.689% |
| NaviFUS Corp. | -123.12 Million TWD | -22.076% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 302.983% |
| Sinew Pharma Inc. | -160.34 Million TWD | 6.258% |
| Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 37.861% |
| Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 55.447% |
| Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 63.573% |
| AP Biosciences Inc | -196.52 Million TWD | 23.517% |
| Medigen Biotechnology Corp. | 688.73 Million TWD | 121.824% |
| 3D Global Biotech Inc. | -11.43 Million TWD | -1214.252% |
| Pharmosa Biopharm Inc. | -829.69 Million TWD | 81.883% |
| Intech Biopharm Corporation | 1.35 Billion TWD | 111.074% |
| Oneness Biotech Co., Ltd. | -414.87 Million TWD | 63.77% |
| Eusol Biotech Co.,Ltd. | -209.33 Million TWD | 28.197% |
| TWi Biotechnology, Inc. | -143.86 Million TWD | -4.482% |
| Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 54.526% |
| TCI GENE Inc. | -689.25 Million TWD | 78.192% |
| MegaPro Biomedical Co., Ltd | -118.93 Million TWD | -26.378% |
| Senhwa Biosciences, Inc. | -1.3 Billion TWD | 88.519% |
| Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 833.833% |
| NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | -47.552% |
| PharmaEngine, Inc. | -860.8 Million TWD | 82.538% |
| Savior Lifetec Corporation | -812.54 Million TWD | 81.501% |
| TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 49.891% |
| OBI Pharma, Inc. | -398.22 Million TWD | 62.255% |
| Meribank Biotech Co., Ltd | -365.41 Million TWD | 58.866% |
| Acepodia, Inc. | -6.02 Billion TWD | 97.503% |
| Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 95.581% |